PTGX logo

Protagonist Therapeutics, Inc. (PTGX) Operating Profit

Annual Operating Profit:

$252.84M+$346.50M(+369.98%)
December 31, 2024

Summary

  • As of today, PTGX annual operating income is $252.84 million, with the most recent change of +$346.50 million (+369.98%) on December 31, 2024.
  • During the last 3 years, PTGX annual operating profit has risen by +$378.69 million (+300.92%).
  • PTGX annual operating profit is now at all-time high.

Performance

PTGX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

Quarterly Operating Profit:

-$42.04M-$22.73M(-117.72%)
June 30, 2025

Summary

  • As of today, PTGX quarterly operating income is -$42.04 million, with the most recent change of -$22.73 million (-117.72%) on June 30, 2025.
  • Over the past year, PTGX quarterly operating profit has dropped by -$3.25 million (-8.37%).
  • PTGX quarterly operating profit is now -120.38% below its all-time high of $206.31 million, reached on March 31, 2024.

Performance

PTGX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

TTM Operating Profit:

$23.98M-$3.25M(-11.93%)
June 30, 2025

Summary

  • As of today, PTGX TTM operating income is $23.98 million, with the most recent change of -$3.25 million (-11.93%) on June 30, 2025.
  • Over the past year, PTGX TTM operating profit has dropped by -$128.26 million (-84.25%).
  • PTGX TTM operating profit is now -90.52% below its all-time high of $252.84 million, reached on December 31, 2024.

Performance

PTGX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

PTGX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+370.0%-8.4%-84.3%
3Y3 Years+300.9%-1.4%+118.0%
5Y5 Years+414.0%-130.8%+138.1%

PTGX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+292.5%-120.4%+0.7%-90.5%+115.7%
5Y5-Yearat high+292.5%-120.4%+0.7%-90.5%+115.7%
All-TimeAll-Timeat high+292.5%-120.4%+0.7%-90.5%+115.7%

PTGX Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$42.04M(-117.7%)
$23.98M(-11.9%)
Mar 2025
-
-$19.31M(-115.2%)
$27.22M(-89.2%)
Dec 2024
$252.84M(+370.0%)
$126.78M(+405.8%)
$252.84M(+69.6%)
Sep 2024
-
-$41.45M(-6.9%)
$149.11M(-2.1%)
Jun 2024
-
-$38.79M(-118.8%)
$152.24M(+2.4%)
Mar 2024
-
$206.31M(+795.1%)
$148.68M(+258.8%)
Dec 2023
-$93.65M(+28.7%)
$23.05M(+160.1%)
-$93.65M(+38.9%)
Sep 2023
-
-$38.33M(+9.5%)
-$153.22M(-4.1%)
Jun 2023
-
-$42.35M(-17.6%)
-$147.19M(-0.6%)
Mar 2023
-
-$36.02M(+1.4%)
-$146.28M(-11.3%)
Dec 2022
-$131.37M(-4.4%)
-$36.52M(-13.0%)
-$131.37M(+0.4%)
Sep 2022
-
-$32.30M(+22.1%)
-$131.87M(+1.2%)
Jun 2022
-
-$41.44M(-96.3%)
-$133.50M(-8.6%)
Mar 2022
-
-$21.11M(+43.0%)
-$122.94M(+2.3%)
Dec 2021
-$125.84M(-95.1%)
-$37.02M(-9.1%)
-$125.84M(-16.9%)
Sep 2021
-
-$33.93M(-9.9%)
-$107.66M(-32.1%)
Jun 2021
-
-$30.88M(-28.6%)
-$81.50M(-18.4%)
Mar 2021
-
-$24.02M(-27.6%)
-$68.84M(-6.7%)
Dec 2020
-$64.52M
-$18.83M(-142.3%)
-$64.52M(-2.4%)
Sep 2020
-
-$7.77M(+57.3%)
-$62.98M(+13.0%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$18.22M(+7.5%)
-$72.38M(+15.4%)
Mar 2020
-
-$19.70M(-13.9%)
-$85.57M(-6.3%)
Dec 2019
-$80.52M(-90.5%)
-$17.30M(-0.8%)
-$80.52M(-2.4%)
Sep 2019
-
-$17.17M(+45.3%)
-$78.63M(-11.0%)
Jun 2019
-
-$31.41M(-114.4%)
-$70.86M(-45.5%)
Mar 2019
-
-$14.65M(+5.0%)
-$48.69M(-15.2%)
Dec 2018
-$42.27M(-11.5%)
-$15.41M(-64.1%)
-$42.27M(-39.2%)
Sep 2018
-
-$9.39M(-1.6%)
-$30.37M(-17.0%)
Jun 2018
-
-$9.24M(-12.3%)
-$25.96M(+18.5%)
Mar 2018
-
-$8.23M(-134.2%)
-$31.85M(+15.9%)
Dec 2017
-$37.90M(-16.0%)
-$3.51M(+29.5%)
-$37.90M(+17.2%)
Sep 2017
-
-$4.98M(+67.1%)
-$45.78M(+4.5%)
Jun 2017
-
-$15.13M(-6.0%)
-$47.94M(-20.2%)
Mar 2017
-
-$14.27M(-25.2%)
-$39.90M(-22.1%)
Dec 2016
-$32.67M(-120.8%)
-$11.40M(-59.7%)
-$32.67M(-24.3%)
Sep 2016
-
-$7.14M(-0.7%)
-$26.27M(-37.3%)
Jun 2016
-
-$7.09M(-0.7%)
-$19.13M(-58.9%)
Mar 2016
-
-$7.04M(-40.8%)
-$12.04M(-56.6%)
Dec 2015
-$14.79M(-58.8%)
-$5.00M(-86.0%)
-$7.69M(-186.0%)
Mar 2015
-
-$2.69M
-$2.69M
Dec 2014
-$9.32M
-
-

FAQ

  • What is Protagonist Therapeutics, Inc. annual operating income?
  • What is the all-time high annual operating profit for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Protagonist Therapeutics, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Protagonist Therapeutics, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. TTM operating profit year-on-year change?

What is Protagonist Therapeutics, Inc. annual operating income?

The current annual operating profit of PTGX is $252.84M

What is the all-time high annual operating profit for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high annual operating income is $252.84M

What is Protagonist Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, PTGX annual operating income has changed by +$346.50M (+369.98%)

What is Protagonist Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of PTGX is -$42.04M

What is the all-time high quarterly operating profit for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high quarterly operating income is $206.31M

What is Protagonist Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, PTGX quarterly operating income has changed by -$3.25M (-8.37%)

What is Protagonist Therapeutics, Inc. TTM operating income?

The current TTM operating profit of PTGX is $23.98M

What is the all-time high TTM operating profit for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high TTM operating income is $252.84M

What is Protagonist Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, PTGX TTM operating income has changed by -$128.26M (-84.25%)
On this page